Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Unique prognostic factors in acral lentiginous melanoma.

Egger ME, McMasters KM, Callender GG, Quillo AR, Martin RC 2nd, Stromberg AJ, Scoggins CR.

Am J Surg. 2012 Dec;204(6):874-9; discussion 879-80. doi: 10.1016/j.amjsurg.2012.05.013.

PMID:
23022254
2.

Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.

Callender GG, Egger ME, Burton AL, Scoggins CR, Ross MI, Stromberg AJ, Hagendoorn L, Martin RC 2nd, McMasters KM.

Am J Surg. 2011 Dec;202(6):659-64; discussion 664-5. doi: 10.1016/j.amjsurg.2011.06.048.

PMID:
22137134
3.

Clinicopathologic and survival differences between upper and lower extremity melanomas.

Egger ME, Tabler BL, Dunki-Jacobs EM, Callender GG, Scoggins CR, Martin RC 2nd, Quillo AR, Stromberg AJ, McMasters KM.

Am Surg. 2012 Jul;78(7):779-87.

PMID:
22748538
4.

Outcomes and prognostic factors in nodular melanomas.

Egger ME, Dunki-Jacobs EM, Callender GG, Quillo AR, Scoggins CR, Martin RC 2nd, Stromberg AJ, McMasters KM.

Surgery. 2012 Oct;152(4):652-9; discussion 659-60. doi: 10.1016/j.surg.2012.07.006.

PMID:
22925134
5.

Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.

Burton AL, Gilbert J, Farmer RW, Stromberg AJ, Hagendoorn L, Ross MI, Martin RC 2nd, McMasters KM, Scoggins CR, Callender GG.

Am Surg. 2011 Aug;77(8):1009-13.

PMID:
21944515
6.

Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?

Mays MP, Martin RC, Burton A, Ginter B, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Stromberg AJ, McMasters KM, Scoggins CR.

Cancer. 2010 Mar 15;116(6):1535-44. doi: 10.1002/cncr.24895.

7.

Diversity of stage III melanoma in the era of sentinel lymph node biopsy.

Egger ME, Callender GG, McMasters KM, Ross MI, Martin RC 2nd, Edwards MJ, Urist MM, Noyes RD, Sussman JJ, Reintgen DS, Stromberg AJ, Scoggins CR.

Ann Surg Oncol. 2013 Mar;20(3):956-63. doi: 10.1245/s10434-012-2701-z.

PMID:
23064795
8.

Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis.

Chagpar RB, Ross MI, Reintgen DS, Edwards MJ, Scoggins CR, Martin RC 2nd, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Davidson BS, Sussman JJ, McMasters KM.

J Surg Res. 2007 Nov;143(1):164-8.

PMID:
17950088
9.

Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.

Murali R, Haydu LE, Quinn MJ, Saw RP, Shannon K, Spillane AJ, Stretch JR, Thompson JF, Scolyer RA.

Ann Surg. 2012 Jan;255(1):128-33. doi: 10.1097/SLA.0b013e3182306c72.

PMID:
21975320
10.

Incidence of sentinel lymph node involvement in a modern, large series of desmoplastic melanoma.

Egger ME, Huber KM, Dunki-Jacobs EM, Quillo AR, Scoggins CR, Martin RC 2nd, Stromberg AJ, McMasters KM, Callender GG.

J Am Coll Surg. 2013 Jul;217(1):37-44; discussion 44-5. doi: 10.1016/j.jamcollsurg.2013.05.006.

PMID:
23791271
11.

Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.

Mandalà M, Imberti GL, Piazzalunga D, Belfiglio M, Labianca R, Barberis M, Marchesi L, Poletti P, Bonomi L, Novellino L, Di Biagio K, Milesi A, Guerra U, Tondini C.

Eur J Cancer. 2009 Sep;45(14):2537-45. doi: 10.1016/j.ejca.2009.05.034.

PMID:
19553103
12.

Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.

Egger ME, Bhutiani N, Farmer RW, Stromberg AJ, Martin RC 2nd, Quillo AR, McMasters KM, Scoggins CR.

Surgery. 2016 May;159(5):1412-21. doi: 10.1016/j.surg.2015.12.002.

PMID:
26775577
13.

Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy.

Pawlik TM, Ross MI, Johnson MM, Schacherer CW, McClain DM, Mansfield PF, Lee JE, Cormier JN, Gershenwald JE.

Ann Surg Oncol. 2005 Aug;12(8):587-96.

PMID:
16021533
14.

Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome?

Fadaki N, Li R, Parrett B, Sanders G, Thummala S, Martineau L, Cardona-Huerta S, Miranda S, Cheng ST, Miller JR 3rd, Singer M, Cleaver JE, Kashani-Sabet M, Leong SP.

Ann Surg Oncol. 2013 Sep;20(9):3089-97. doi: 10.1245/s10434-013-2977-7.

PMID:
23649930
15.

Lymphovascular invasion as a prognostic factor in melanoma.

Egger ME, Gilbert JE, Burton AL, McMasters KM, Callender GG, Quillo AR, Brown RE, St Hill CR, Hagendoorn L, Martin RC 2nd, Stromberg AJ, Scoggins CR.

Am Surg. 2011 Aug;77(8):992-7.

PMID:
21944512
16.

Sentinel lymph node status is the most important prognostic factor in patients with melanoma of the scalp.

Cappello ZJ, Augenstein AC, Potts KL, McMasters KM, Bumpous JM.

Laryngoscope. 2013 Jun;123(6):1411-5. doi: 10.1002/lary.23793.

PMID:
23625541
17.

Clinical impact of sentinel lymph node biopsy in patients with thick (>4 mm) melanomas.

White I, Fortino J, Curti B, Vetto J.

Am J Surg. 2014 May;207(5):702-7; discussion 707. doi: 10.1016/j.amjsurg.2013.12.022.

PMID:
24791630
18.

Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.

Roka F, Kittler H, Cauzig P, Hoeller C, Hinterhuber G, Wolff K, Pehamberger H, Diem E.

Br J Cancer. 2005 Feb 28;92(4):662-7.

19.

Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.

Cherpelis BS, Haddad F, Messina J, Cantor AB, Fitzmorris K, Reintgen DS, Fenske NA, Glass LF.

J Am Acad Dermatol. 2001 May;44(5):762-6.

PMID:
11312421
20.

Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.

Debarbieux S, Duru G, Dalle S, Béatrix O, Balme B, Thomas L.

Br J Dermatol. 2007 Jul;157(1):58-67.

PMID:
17501957
Items per page

Supplemental Content

Support Center